Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Efficacy and effects on quality of life. RSD [Internet]. 2025 May 14 [cited 2025 Jun. 28];14(5):e4914548812. Available from: https://ojs34.rsdjournal.org/index.php/rsd/article/view/48812